Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)

समान संसाधन

• Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
  द्वारा: Horneff G, और अन्य
  प्रकाशित: (2008-09-01)
• Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
  द्वारा: Horneff, Gerd, और अन्य
  प्रकाशित: (2016)
• The German etanercept registry for treatment of juvenile idiopathic arthritis
  द्वारा: Horneff, G, और अन्य
  प्रकाशित: (2004)
• Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
  द्वारा: Horneff, G, और अन्य
  प्रकाशित: (2011)
• Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
  द्वारा: Armaroli, Giulia, और अन्य
  प्रकाशित: (2020)